Related Experiment Video
Updated: Aug 21, 2026

Angiogenesis in the Ischemic Rat Lung
Published on: February 8, 2013
[Inflammatory injurious effect of angiotensin II on pulmonary microvascular endothelium in rat]
1Department of Emergency, First Affiliated Hospital, Anhui Medical University, Hefei 230061, Anhui, China.
Objective:
To investigate the effects of angiotensin II (AngII) and its receptors on monolayer permeability of pulmonary microvascular endothelial cells in rat.
Methods:
The following examinations were done on cultured rat pulmonary microvascular endothelial cells (RPMVECs). 1. Micro-filter was used to assay the variations of lipopolysaccharide (LPS)-induced increased RPMVECs monolayer permeability coefficient (Kf) in different periods. 2. Effect of angiotensin II on LPS-induced permeability injury to the endothelium, and preventive effects of angiotensin II type 1 receptor antagonist (Sar1, Ile8)-Ang II.
Results:
LPS increased RPMVECs monolayer permeability compared with normal control, and AngII exacerbated LPS-induced RPMVECs monolayer permeability significantly. This synergistic effect was significantly prevented by the addition of (Sar1, Ile8 )-Ang II.
Conclusion:
AngII and LPS have synergistic injurious effects to the pulmonary microvascular endothelium in rat, and AngII exacerbates increase in LPS-induced RPMVECs monolayer permeability. This synergistic effect is significantly prevented by the addition of (Sar1, Ile8)-Ang II.
Insights
Angiotensin II (AngII) worsens lung microvascular endothelial cell injury caused by lipopolysaccharide (LPS). Blocking the Angiotensin II type 1 receptor prevents this combined damage, suggesting a therapeutic target.
Area of Science:
- Pulmonary vascular research
- Endothelial cell biology
- Cardiovascular pharmacology
Context:
- Pulmonary microvascular endothelial cells (RPMVECs) form a critical barrier in the lungs.
- Endothelial barrier dysfunction is implicated in acute lung injury.
- Angiotensin II (AngII) plays a role in vascular regulation and inflammation.
Purpose:
- To investigate the synergistic effects of AngII and lipopolysaccharide (LPS) on RPMVEC monolayer permeability.
- To determine if blocking the Angiotensin II type 1 receptor can prevent AngII and LPS-induced endothelial injury.
Summary:
- Lipopolysaccharide (LPS) significantly increased RPMVEC monolayer permeability.
- Angiotensin II (AngII) exacerbated LPS-induced permeability, indicating a synergistic injurious effect.
- (Sar1, Ile8)-Ang II, an Angiotensin II type 1 receptor antagonist, significantly prevented this synergistic damage.
Impact:
- This study highlights the detrimental interaction between AngII and LPS in the pulmonary endothelium.
- Targeting the Angiotensin II type 1 receptor may offer a therapeutic strategy to mitigate LPS-induced lung injury.
- Findings contribute to understanding endothelial dysfunction in critical care settings.

